Back

Additional value of an integrated Polygenic Risk Score to a conventional tool in the prediction of cardiovascular events in an asymptomatic population

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (6) Scores ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Debora Sa

Hospital Dr. Nelio Mendonca, Funchal (Portugal)

5 More presentations in this session

Presentation thumbnail
High-sensitivity CRP to HDL-C ratio as a novel inflammatory-lipid biomarker for mortality risk prediction: a prospective population-based cohort study
Doctor Y. Zhao (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The potential impact of residual inflammation and elevated Lipoprotein (a) levels in long-term cardiovascular patients' survival
Doctor M. Ferreira (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Relation of Lp(a) with plaque characteristics and clinical events: ATHEROREMO and IBIS_3 cohorts
Doctor J. Veiga-Fernandes Mira (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Circulating Lipoprotein(a) and Non-culprit Lipid-rich Plaques in Acute Coronary Syndrome and Stable Coronary Artery Disease: Findings from Near-infrared Spectroscopy Imaging Analysis
Doctor T. Iwai (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Global cardiac microcalcification activity and the risk of cardiovascular events
Doctor M. Grine (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors (6)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Development and validation of a risk prediction algorithm for high-risk populations combining genetic and conventional risk factors of cardiovascular disease
thumbnail
Congress Presentation
Cardiovascular risk prediction using metabolomic biomarkers and polygenic risk scores: a cohort study and modelling analyses
thumbnail
Congress Session
Coronary heart disease risk prediction in asymptomatic patients: what works best?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources